AI assistant
Convatec Group PLC — Director's Dealing 2019
May 17, 2019
4959_dirs_2019-05-17_369a67f8-6393-4c21-a7cd-ce4c758b5ea3.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 4360Z
ConvaTec Group PLC
17 May 2019
17 May 2019
ConvaTec Group Plc
("ConvaTec" or "the Company")
Director/PDMR Shareholding
The Company has been notified of the following transaction by a Person Discharging Managerial Responsibility ("PDMR") in ordinary shares of 10 pence each in the share capital of the Company ("Shares").
On 16 May 2019 Mr Rick Anderson, Executive Chairman and Chief Executive Officer, acquired 1,680 Shares at £1.3728 per share as part of the Scrip Dividend Scheme. Mr Anderson's resulting shareholding is 206,655 Shares.
The attached notification, made in accordance with the requirements of the EU Market Abuse Regulation, gives further detail.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||
| a) | Name | Mr Rick Anderson | ||
| 2 | Reason for the notification | |||
| a) | Position/Status | Executive Chairman and Chief Executive Officer | ||
| b) | Initial notification/Amendment | Initial notification | ||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||
| a) | Name | ConvaTec Group Plc | ||
| b) | LEI | 213800LS272L4FIDOH92 | ||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||
| a) | Description of the financial instrument, type of instrument Identification code |
Ordinary shares of 10p each in ConvaTec Group Plc ("Shares") GB00BD3VFW73 |
||
| b) | Nature of the transaction | Acquisition of Shares via Scrip Dividend Scheme | ||
| c) | Price(s) and volume(s) | Price(s) £1.3728 |
Volume(s) 1680 |
|
| d) | Aggregated information - Aggregated volume - Price |
1680 £2,306.31 |
||
| e) | Date of the transaction | 16 May 2019 | ||
| f) | Place of the transaction | London Stock Exchange, Main Market (XLON) | ||
Enquiries
Media
Bobby Leach, VP Group Corporate Affairs, ConvaTec +44 (0)7770 842 226
Finsbury +44 (0)207 251 3801
Analysts and Investors
John Crosse, VP Investor Relations, ConvaTec +44 (0)7500 141 435
Mark Reynolds, Director Investor Relations, ConvaTec +44 (0)7551 036 625
ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92
About ConvaTec
ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. ConvaTec's products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com where a copy of this announcement can also be found.
END
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
DSHLLFILESIDLIA